Ying Fang Jiang

age ~52

from Kenosha, WI

Get Report

Also known as:

Connected to:

Ying Jiang Phones & Addresses

view source

Licenses:

New York - Currently registered 2012

Education:

Washington University IN St. Louis

view source

Author
Ying Jiang

ISBN #
7507518205

G-Protein Coupled Receptor Ligands And Methods
view source
US Patent:

7338772, Mar 4, 2008
Filed:

Apr 10, 2003
Appl. No.:

10/411545
Inventors:

Ying Jiang - Scotch Plains NJ, US
Fang Liang Zhang - Fanwood NJ, US
Nicholas J. Murgolo - Millington NJ, US
Lin Luo - Edison NJ, US
Jason S. Simon - Westfield NJ, US
Assignee:

Schering Corporation - Kenilworth NJ
International Classification:

G01N 33/566
US Classification:

435 721, 435 72, 436501
Abstract:

The present invention relates to RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate the receptor.

G-Protein Coupled Receptor Ligands And Methods
view source
US Patent:

7807390, Oct 5, 2010
Filed:

Jan 7, 2008
Appl. No.:

11/970276
Inventors:

Ying Jiang - Scotch Plains NJ, US
Fang Liang Zhang - Fanwood NJ, US
Nicholas J. Murgolo - Millington NJ, US
Lin Luo - Edison NJ, US
Jason S. Simon - Westfield NJ, US
Assignee:

Schering Corporation - Kenilworth NJ
International Classification:

G01N 33/566
C07K 14/705
US Classification:

435 721, 435 71, 435 72, 436501
Abstract:

The present invention relates to RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate the receptor.

Antibodies And Functional Fragments Thereof That Specifically Bind An Rf-Amide Peptide Or A Precursor Thereof
view source
US Patent:

8133980, Mar 13, 2012
Filed:

Oct 1, 2010
Appl. No.:

12/896297
Inventors:

Ying Jiang - Scotch Plains NJ, US
Fang Liang Zhang - Fanwood NJ, US
Nicholas J. Murgolo - Millington NJ, US
Lin Luo - Edison NJ, US
Jason S. Simon - Westfield NJ, US
Assignee:

Schering Corporation - Kenilworth NJ
International Classification:

C07K 16/00
C12P 21/08
US Classification:

5303879, 5303881, 53038815, 4241391
Abstract:

The present invention relates to RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate the receptor.

Methods, Mediums, And Systems For Testing Fiber Optic Telecommunication Systems
view source
US Patent:

20230062982, Mar 2, 2023
Filed:

Aug 28, 2021
Appl. No.:

17/460182
Inventors:

- Eatontown NJ, US
D. Mark Havens - Wall NJ, US
Robert P. Bellomo - Montclair NJ, US
Bamdad Bakhshi - Asbury Park NJ, US
Robert Behringer - Monmouth Beach NJ, US
Roberto Mattos - Morganville NJ, US
Ying Jiang - Metuchen NJ, US
William C. Barnett - Freehold NJ, US
Mark Enright - Hampton NJ, US
Assignee:

SUBCOM, LLC - Eatontown NJ
International Classification:

H04B 10/07
Abstract:

This application describes techniques for testing fiber optic telecommunication systems, such as undersea fiber optic cable systems. Testing terminals may be deployed at a location of terminating equipment for a fiber optic cable. The testing terminals may be operated remotely. The testing terminals may be configured to programmatically test the cable by loading one or more tests and automatically configure the cable's transmitters and receivers based on predetermined loading schemes selected based on the tests to be performed. The testing terminals may iterate over channels and fiber pairs of the cable and may use back-to-back tests to remove artifacts from test results. Using the described techniques, a cable's channels and fiber pairs can be fully characterized in the amount of time afforded for a typical testing schedule, which was not generally possible using conventional testing.

Transdermal Delivery Of Phenethylamine Monoamine Releasers
view source
US Patent:

20190298661, Oct 3, 2019
Filed:

Oct 31, 2017
Appl. No.:

16/346180
Inventors:

- Macon GA, US
Ajay K. Banga - Duluth GA, US
Sindhu S. Ganti - Atlanta GA, US
Ying Jiang - Atlanta GA, US
Ashana Puri - Atlanta GA, US
International Classification:

A61K 9/70
A61K 31/5375
A61K 31/4465
A61K 9/00
Abstract:

Transdermal patches and transdermally applyable pharmaceutical compositions containing an effective amount of at least one drug are disclosed. The at least one drug may be: (a) phenmetrazine; (b) 4-benzylpiperidine; (c) 3-flouroamphetamine; (d) a DA/NE releaser compound having formula (I): wherein each of R, R, R, R, R, R, R, R, Rand Ris independently hydrogen, a halogen, a substituted or unsubstituted alkyl group, or a substituted or unsubstituted alkoxy group, and when one or more substituents is present on an alkyl group, an alkoxy group, or both, each substituent is independently a halogen; or (e) any combination thereof. Methods of making transdermal patches and transdermally applyable pharmaceutical compositions and methods of using transdermal patches and transdermally applyable pharmaceutical compositions are also disclosed.